Advertise on podcast: Findmyvaccine

Episode Description RSV prevention now comes with options. Great news—until you have to decide who gets what, when, and how to make sure it actually happens. 🦠💉 In Part 2 of our conversation, infectious disease specialist Dr. Zain Chagla returns to the FindMyVaccine Podcast to take RSV prevention from the guideline page to the front lines. First up: timing really is everything. A baby born during RSV season may be best protected before leaving hospital. A baby born in July? Not so fast. Dr. Chagla explains why the goal isn’t simply to immunize at the earliest opportunity—it’s to line up the protection window with the infant’s period of greatest RSV exposure. Think less “ASAP” and more “right place, right season.” Then comes the big practical question: maternal vaccination or infant monoclonal antibody? We unpack gestational timing, the important two-week window before delivery, infant risk factors, family preference, local program availability—and why this conversation belongs in the birth plan, not as a surprise item at discharge. With multiple monoclonal antibody options now in the toolkit, we also ask: how do you actually choose one? Dr. Chagla walks through dosing, age and season indications, access, inventory and workflow considerations. And because guidelines always sound easier until an actual patient walks in, we put Zain through a special rapid-fire RSV rounds. ⚡ Four babies. Four different scenarios. No multiple-choice answers. A healthy baby born in July. A newborn delivered nine days after maternal RSV vaccination. A premature infant. A 14-month-old with chronic lung disease heading into season two. Dr. Chagla offers a practical way to explain risk without frightening parents or overselling protection. Finally, we finish with a Monday-morning checklist for clinicians. Because ultimately, the best RSV strategy isn’t necessarily the fanciest one.   Learning Objectives By the end of this episode, listeners will be able to: Apply RSV seasonality to prevention timing, distinguishing the approach for infants born during versus outside peak RSV activity. Compare maternal RSV vaccination and infant monoclonal antibody strategies, considering gestational timing, infant risk, family preference and local program availability. Recognize situations where monoclonal antibody protection may still be appropriate, including insufficient time between maternal vaccination and delivery or increased infant risk. Evaluate practical factors involved in monoclonal antibody selection, including authorized indications, dosing, age, workflow, accessibility and second-season considerations. Apply RSV prevention recommendations to common real-world cases, including healthy infants, premature newborns and medically high-risk children. Counsel parents about RSV risk in a balanced and understandable way, setting realistic expectations about what preventive interventions can—and cannot—do. Identify practical system changes that can improve RSV prevention, #FindMyVaccine ️ #RSV #RSVPrevention  #MonoclonalAntibodies #MaternalVaccination #PassiveImmunization #Pediatrics #InfectiousDiseases  #NACI #PublicHealth #ClinicalPractice #VaccineEducation #NewbornHealth #CanadianHealthcare SUPPORTED BY AN IME GRANT FROM MERCK.       About Dr. Zain Chagla HAMILTON, ON  Dr.Zain  Chagla, MD MSc MD, FRCPC  is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.  Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.  As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He  has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a  prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.

Episode Description RSV prevention has entered its “more options, more questions” era. 👶🦠 In Part 1, infectious disease specialist Dr. Zain Chagla returns to the FindMyVaccine Podcast to help sort through what Canadian clinicians actually need to know about protecting infants from RSV. First up: who is really at risk? Spoiler—the answer is not just premature or medically fragile babies. Dr. Chagla explains why otherwise healthy, full-term infants can still end up hospitalized with RSV, why those first few months of life matter so much, and how to communicate that risk to families without turning counselling into a horror movie. We then tackle the updated NACI guidance and the increasingly important choice between maternal vaccination and long-acting monoclonal antibodies. Who should receive what? When does maternal vaccination leave an infant needing additional protection? And which higher-risk babies deserve a particularly proactive plan? Then comes the immunology—minus the painful lecture. Dr. Chagla explains why monoclonal antibodies are not vaccines, how passive immunization essentially gives infants ready-made RSV-fighting antibodies, and why newer long-acting options have changed the game from repeated injections to protection that can potentially cover much of an RSV season. And because percentages alone rarely tell the whole story, we dig into the evidence: pivotal trials, hospitalization outcomes, absolute risk reduction, high-risk infant data, and why comparing one RSV monoclonal antibody trial directly with another can get scientifically… messy. Bottom line: RSV prevention is no longer simply about knowing that options exist. It is about knowing which option, for which infant, at which time. Class is officially in session. 🎙️ Learning Objectives By the end of this episode, listeners will be able to: Describe the clinical burden of RSV in infants and explain why severe disease can occur even in previously healthy, full-term babies. Interpret updated Canadian RSV prevention guidance, including the respective roles of maternal vaccination and infant monoclonal antibodies. Identify infants who may warrant a more proactive monoclonal antibody strategy, including those with prematurity, cardiopulmonary disease, immunodeficiency, other medical risk factors, or barriers to timely healthcare access. Explain the difference between vaccination and passive immunization, including how long-acting monoclonal antibodies provide immediate protection against RSV. Translate RSV clinical trial results into practical clinical meaning, including relative efficacy, absolute reductions in hospitalization, and important limitations when comparing evidence across trials. Apply seasonality and local RSV surveillance when considering the timing of infant prevention strategies. #FindMyVaccine  #RSV #RSVPrevention #InfantHealth #MonoclonalAntibodies #MaternalVaccination #PassiveImmunization #NACI #Pediatrics #InfectiousDiseases  #PublicHealth #CanadianHealthcare Supported by an IME Grant from Merck       Dr. Zain Chagla Dr.Zain  Chagla, MD MSc MD, FRCPC  is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.  Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.  As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He  has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a  prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.

☎  What happens when you put BC’s biggest healthcare pain points on the table—and agree that “we’ve always done it this way” isn’t a strategy? 🗨️  In this special episode, BC Premier David Eby, joins us for a sit down candid, practical conversation about the realities of modernizing healthcare in British Columbia—starting with the unglamorous but high-impact stuff: cutting administrative duplication across health authorities, centralizing procurement and shared services, and creating clearer accountability so problems get fixed faster.  🎙️We explore what frontline clinicians want: a tighter feedback loop where ideas from pharmacists, nurses, physicians, and allied health don’t disappear into a “suggestion box” black hole and unpack the real promise—and real limits—of AI integration into day to day healthcare across BC: where it’s already helping, and what it takes to scale innovation safely with privacy protections.  🎙️BC Cancer—and the growing operational pressure of rising diagnoses, delayed access, and complex patient journeys. Premier Eby shares what’s underway and tackles a question that may be on the minds of HCPs and caregivers: do we need to revisit BC’s 10-year cancer plan to match today’s system realities and  explore practical system fixes like patient navigators om the BC Cancer care pathway.  🎙️You’ll also hear a frank discussion on expanding pharmacy-delivered care, the pressures and possibilities of minor ailments and contraceptive services, and how new reimbursement models may unlock pharmacist impact beyond the walls of a community pharmacy.  🎙️This episode arguably tackles some of the toughest files facing the Ministry of Health: rare-disease drug reimbursement decisions, transparency and modernization in PharmaCare, balancing urgent access with fair pricing, and what meaningful accountability looks like when care delivery goes wrong.We also unpack regulation and oversight through the Health Professions Act: is it enough to protect the public and drive system-level learning, or do we need additional tools in the middle ground between individual college complaints and full-blown litigation? ▶️If you’re a frontline clinician, health leader, or policy-watcher who wants less theatre and more solutions—this one’s for you. 💡💡 In this episode, we look at: The role of a new provincial “shared services” model and health authority optimization What a province-wide AI strategy needs before it touches routine prescribing workflows Where pharmacist scope is heading—and what may be missing to make it sustainable Why rare-disease drug coverage decisions feel like a black box (and how to fix that) and Pharmacare The case for better patient navigation during their cancer care journey In collaboration with the Pharmacy Leaders of Tomorrow.   VODCAST AVAILABLE HERE; https://www.myvaccinepodcast.com/vodcast Reach us at:  [email protected] or [email protected]   Our hearts are with everyone affected—along with their families, friends, and the Tumbler Ridge, B.C. community—coping  with an unimaginable loss during this heartbreaking time.    ABOUT BC Premier Hon. David Eby, KC David Eby is a determined problem-solver who has spent a lifetime taking on powerful interests to get things done for people. As Premier of B.C., David is taking action on the biggest challenges facing British Columbians. He’s standing up to wealthy speculators and investors to deliver more homes middle-class people can afford. He’s working to ease the pressure of everyday costs, from reducing car insurance and childcare bills to making prescription birth control free. And he’s strengthening health care by building hospitals and hiring more family doctors. Under David’s leadership, B.C. is an economic leader in Canada—creating tens of thousands of good-paying jobs to deliver the lowest unemployment rate and some of the fastest growing wages in the country. Alongside John Horgan, David got the influence of big money out of B.C.’s elections and cracked down on money laundering in casinos and real estate. He took on opioid manufacturers and delivered a first-of-its-kind settlement to hold corporations accountable for the overdose crisis. He stood up to the trial lawyers and removed legal costs from ICBC process to reduce car insurance rates by an average of $500 a year for drivers.  He even went after organized crime—closing down Hells Angels clubhouses and targeting the proceeds of crime to make our communities safer. Before being elected as the MLA for Vancouver-Point Grey, David was an award-winning lawyer and legal scholar. He started his career on Vancouver’s Downtown Eastside, defending the homes of low-income people from big developers and slum lords. His work on human rights and democratic freedoms has been recognized by the United Nations Association in Canada and the B.C. Human Rights Coalition. David was an adjunct professor of law at the University of British Columbia, president of the HIV-AIDS Legal Network, and served on the Vancouver Foundation’s Health and Social Development Committee. From 2009 to 2013, David ran the B.C. Civil Liberties Association as executive director. David was raised in a suburban middle-class home. The son of a schoolteacher and a lawyer, he remains grounded in the values he grew up with – commitment to family, community, and helping the less fortunate. He is now a proud husband and father with three children of his own, Ezra, Iva, and baby Gwen. He loves playing with his kids, practising yoga and hanging out with his wife Cailey, a family doctor in Vancouver. As B.C.’s 37th premier, David is working hard to build a better, stronger future for everyone. Because he believes his kids and all British Columbians deserve the same opportunities to build a good life.    #BCPolitics #BCHealth #Healthcare #CanadianHealthcare #HealthPolicy #HealthSystemReform #PrimaryCare #PatientSafety #QualityOfCare #PatientExperience #Accountability #PatientQualityCareReviewBoard #HealthProfessionsAct #Regulation #FrontlineHealthcare #Doctors #Nurses #Pharmacists #PharmacyPractice #ScopeOfPractice #MinorAilments #ContraceptionCare #WaitTimes #HealthEquity #DigitalHealth #AIinHealthcare #Innovation #CancerCare #BCCancer #Oncology #CancerPlan #PatientNavigation

🍁Policing, Policy & Public Health: A Candid Conversation with Chief Adam Palmer We sit down with Adam Palmer, outgoing Chief of the Vancouver Police Department (VPD) and newly appointed RCMP Assistant Commissioner, for a frank, highly practical look at where law enforcement, social policy, mental health, and substance use collide—what’s working, what isn’t, and how health + public safety might be able to row in the same direction. Audience. a clinician, policymaker, or community leader  What we dive into with our guest: Decriminalization—lessons learned: why BC police initially supported a health-first path, what didn't work (public order + weak care pathways), and what guardrails are needed for real-world success.Integrated care pathways: inside Vancouver’s police–nurse partnerships (Car 87/88, Assertive Outreach, psych nurses in the command centre), with cohorts showing impact on police calls and ED visits.Targeting harm, not illness: how “Task Force Barrage” a city-aligned surge focused on violent offenders, traffickers, criminal networks alongside city sanitation and bylaw action-while reaffirming you can’t arrest your way out of social problems.Policy priorities for federal leaders:  bail reform for chronic violent offenders and scaling compassionate/secure care capacity for the small, high-risk subset chronically dangerous to themselves or others.AI readiness for health + public safety:  patient safety implications, and practical risk controls.How HCPs can help today: shared data pathways, and clinic-to-street feedback loops that improve triage and outcomes.  Chief Palmer argues for: Stronger three-level government alignmentThoughtful bail reform for chronic violent offendersScaled “compassionate mandatory / secure care” capacity for the small but high-risk subset that may be dangerous to themselves/othersContinued integration with healthcare as AI risks and city growth accelerate.    Guest Note: Adam Palmer served as VPD Chief (2015–2025) and has just announced his new role as Assistant Commissioner with the RCMP, attached to National HQ (Ottawa) while remaining based in BC.   ABOUT CHIEF CONSTABLE ADAM PALMER CHIEF CONSTABLE ADAM PALMER took command as the 31st Chief Constable of the Vancouver Police Department on May 6th, 2015. Chief Palmer was born and raised in the Vancouver area. Prior to joining the Vancouver Police, he studied Business Administration at Simon Fraser University and worked as a correctional officer. Chief Palmer began his career with the VPD in 1987 and since that time has worked in a variety of operational, investigative and administrative areas. He previously managed a long-term review of policing operations in Vancouver that resulted in improved efficiencies, the optimization of existing resources and significant increases in sworn and civilian police staffing. He was a Venue Commander during the 2010 Winter Olympics where he oversaw the security of figure skating and speed skating events. Chief Palmer was President of the Canadian Association of Chiefs of Police (CACP) from 2018-2020 and served on the CACP Board of Directors as Past President until August 2022. He served on the Board of Directors for the International Association of Chiefs of Police (IACP) from 2018 to 2020. In January 2019, Chief Palmer was elected to and currently serves on the Board of Directors for the Major Cities Chief Association (MCCA), which represents the largest police departments in the United States and Canada. Chief Palmer also serves as Chair of the Combined Forces Special Enforcement Unit (CFSEU) Board of Directors, is a member of the National Executive Committee for the Criminal Intelligence Service of Canada (CISC), the Metro Vancouver Transit Police Board of Directors and the Criminology Advisory Committee for Kwantlen Polytechnic University. He is also a former Board member of the Canadian Police Knowledge Network (CPKN). In 2023, Chief Palmer became a Board Member for the Police Executive Research Forum (PERF), a police research and policy organization. In 2009, Chief Palmer was invested as a Member of the Order of Merit of the Police Forces and in 2017 was promoted to the rank of Officer of the Order of Merit of the Police Forces. In 2020, in recognition of the national and international scope of his service and leadership, the Governor General of Canada advanced Chief Palmer to the highest rank within the Order of Merit of the Police Forces, the rank of Commander. In 2021, Chief Palmer received the Major Cities Chiefs Association Leadership Award, the first Canadian police officer to receive this honour. In 2022, he received the CACP’s Recognition Award for developing a national mentorship program for police executive leaders. As Past President of the CACP, Chief Palmer was chosen to receive the King Charles III Coronation Medal in 2024. He is the recipient of nine Vancouver Police Department Commendations and is a former VPD Police Officer of the Year.

🍁Policing, Policy & Public Health: A Candid Conversation with Chief Adam Palmer We sit down with Adam Palmer, outgoing Chief of the Vancouver Police Department (VPD) and newly appointed RCMP Assistant Commissioner, for a frank, highly practical look at where law enforcement, social policy, mental health, and substance use collide—what’s working, what isn’t, and how health + public safety might be able to row in the same direction. Audience. a clinician, policymaker, or community leader  What we dive into with our guest: Decriminalization—lessons learned: why BC police initially supported a health-first path, what didn't work (public order + weak care pathways), and what guardrails are needed for real-world success.Integrated care pathways: inside Vancouver’s police–nurse partnerships (Car 87/88, Assertive Outreach, psych nurses in the command centre), with cohorts showing impact on police calls and ED visits.Targeting harm, not illness: how “Task Force Barrage” a city-aligned surge focused on violent offenders, traffickers, criminal networks alongside city sanitation and bylaw action-while reaffirming you can’t arrest your way out of social problems.Policy priorities for federal leaders:  bail reform for chronic violent offenders and scaling compassionate/secure care capacity for the small, high-risk subset chronically dangerous to themselves or others.AI readiness for health + public safety:  patient safety implications, and practical risk controls.How HCPs can help today: shared data pathways, and clinic-to-street feedback loops that improve triage and outcomes.  Chief Palmer argues for: Stronger three-level government alignmentThoughtful bail reform for chronic violent offendersScaled “compassionate mandatory / secure care” capacity for the small but high-risk subset that may be dangerous to themselves/othersContinued integration with healthcare as AI risks and city growth accelerate.    Guest Note: Adam Palmer served as VPD Chief (2015–2025) and has just announced his new role as Assistant Commissioner with the RCMP, attached to National HQ (Ottawa) while remaining based in BC.   ABOUT CHIEF CONSTABLE ADAM PALMER CHIEF CONSTABLE ADAM PALMER took command as the 31st Chief Constable of the Vancouver Police Department on May 6th, 2015. Chief Palmer was born and raised in the Vancouver area. Prior to joining the Vancouver Police, he studied Business Administration at Simon Fraser University and worked as a correctional officer. Chief Palmer began his career with the VPD in 1987 and since that time has worked in a variety of operational, investigative and administrative areas. He previously managed a long-term review of policing operations in Vancouver that resulted in improved efficiencies, the optimization of existing resources and significant increases in sworn and civilian police staffing. He was a Venue Commander during the 2010 Winter Olympics where he oversaw the security of figure skating and speed skating events. Chief Palmer was President of the Canadian Association of Chiefs of Police (CACP) from 2018-2020 and served on the CACP Board of Directors as Past President until August 2022. He served on the Board of Directors for the International Association of Chiefs of Police (IACP) from 2018 to 2020. In January 2019, Chief Palmer was elected to and currently serves on the Board of Directors for the Major Cities Chief Association (MCCA), which represents the largest police departments in the United States and Canada. Chief Palmer also serves as Chair of the Combined Forces Special Enforcement Unit (CFSEU) Board of Directors, is a member of the National Executive Committee for the Criminal Intelligence Service of Canada (CISC), the Metro Vancouver Transit Police Board of Directors and the Criminology Advisory Committee for Kwantlen Polytechnic University. He is also a former Board member of the Canadian Police Knowledge Network (CPKN). In 2023, Chief Palmer became a Board Member for the Police Executive Research Forum (PERF), a police research and policy organization. In 2009, Chief Palmer was invested as a Member of the Order of Merit of the Police Forces and in 2017 was promoted to the rank of Officer of the Order of Merit of the Police Forces. In 2020, in recognition of the national and international scope of his service and leadership, the Governor General of Canada advanced Chief Palmer to the highest rank within the Order of Merit of the Police Forces, the rank of Commander. In 2021, Chief Palmer received the Major Cities Chiefs Association Leadership Award, the first Canadian police officer to receive this honour. In 2022, he received the CACP’s Recognition Award for developing a national mentorship program for police executive leaders. As Past President of the CACP, Chief Palmer was chosen to receive the King Charles III Coronation Medal in 2024. He is the recipient of nine Vancouver Police Department Commendations and is a former VPD Police Officer of the Year.

🎙️ CIC 2024: NACI, Real World Evidence and  Pharmacoeconomic Modeling with Dr. Jesse Papenburg 🎙️ We sit down with dynamic public health leader and clinician scientist Dr. Jesse Papenburg—a member of the National Advisory Committee on Immunization (NACI) and the Quebec Immunization Committee, where he leads the influenza and RSV working groups, respectively,  and the voice behind some of the latest vaccine recommendations 💉. We unpack the science behind high-dose, adjuvanted, and recombinant influenza vaccines 🧬🩺, specifically tailored for adults 65+. Discover how these specialized vaccines offer enhanced protection by boosting immune responses where it counts the most 🚀💪. Dr. Jesse Papenburg also sheds light on the groundbreaking RSV vaccines designed to shield older adults from severe respiratory illnesses 🤧🛡️ With behind the scenes insights into how cost-effectiveness, real-world efficacy, and economic modeling factor behind NACI's recommendations 📊💡, this episode delivers both the technical deep dive and the human touch that brings public health to life ❤️.And for a refreshing twist, learn about Jesse Papenburg's off-duty passion 😎🥏. Learning Objectives: Decipher the Vaccine Jargon: Understand why high-dose, adjuvanted, and recombinant influenza vaccines are revolutionizing protection for adults 65+ and 75+ 🕵️‍♂️💉.RSV Revealed: Gain insight into the new RSV vaccines for seniors, how they reduce the risk of severe respiratory infections, and why they're becoming a critical tool in our public health arsenal 🛡️📊.Risk Factors & Real Talk: Explore how age, comorbidities, and living environments like long-term care facilities amplify risks—and why personalized vaccine strategies are essential in today’s healthcare landscape 🏥🔍.Tech Talk + Public Health: Delve into the emerging role of AI and predictive modeling in shaping future vaccination policies, offering a fresh perspective on how data-driven insights are changing the game 🤖🚀NACI's Art of Decision Making:  Behind the scenes insights into how cost-effectiveness, real-world efficacy, and economic modeling factor behind NACI's recommendations 📊💡Whether you're a healthcare provider seeking the latest evidence-based updates or a public health policy buff, this episode promises a perfect blend of scientific rigor, practical insights, and a dash of fun! 🎧✨   About Dr. Jesse PapenburgDr. Jesse Papenburg practices Pediatric Infectious Diseases and Medical Microbiology at the Montreal Children’s Hospital of the McGill University Health Centre. After his specialty training, Dr. Papenburg completed a research fellowship on the molecular virology of RNA respiratory viruses at Laval University and an MSc in epidemiology at McGill. As a clinician scientist, he studies the epidemiology of viral respiratory infections. Dr. Papenburg is a member of the National Advisory Committee on Immunization and the Quebec Immunization Committee where he leads the influenza and RSV working groups, respectively.

🍞🥖💉Ever heard of a sourdough geek who also happens to be a rockstar vaccine expert? Join host 🤓 Dr. Carolyn Quash on the Find My Vaccine Podcast as she kneads out the details with immunization guru  🏅 Dr. Caroline Quach—fresh from Quebec 🍁 and fresh out of flour! From sprinkling dough across her kitchen (sorry, husband!) to sprinkling wisdom on immunocompromised patient care 🏥🛡, Dr. Quach dishes on how precision vaccinology 💡, AI-driven modeling 🤖, and big-data insights 📊 are stirring up a brand-new recipe for public health guidance. Get ready to rise to the occasion—and maybe rise some bread on the side! 🍞🔥 Learning Objectives 🎯 Sourdough & Science 🥖🔬: Understand how baking bread (yes, really!) parallels the trial-and-error approach in developing vaccination recommendations.Immunocompromised Insights 💊🤝: Learn the biggest challenges (and breakthroughs) in vaccinating special patient populations—especially those under biologics or CAR T-cell therapies.Modeling & More 🤖🔎: Discover how in silico trials, predictive modeling, and AI might shape tomorrow’s vaccination schedules.Policy in Action 🏛⚖️: Grasp the role of NACI in translating groundbreaking research into real-world immunization guidance.Don’t miss this chance ⏰ to raise your knowledge, feed your curiosity, and find the perfect recipe for innovative vaccine strategies! Tune in now, and let’s get kneading! 🥖🎙️💉   About Dr. Caroline QuachDr. Caroline Quach is a Professor in the Departments of Microbiology, Infectious Diseases & Immunology and of Pediatrics at University of Montreal. She is an adjunct Professor in the Department of Epidemiology, Biostatistics & Occupational Health at McGill University and a scientific collaborator at the School of Public Health at Université Libre de Bruxelles (ULB) in Brussels. She is the physician in charge of Infection Prevention and control at CHU Sainte-Justine where she also works as a pediatric infectious diseases specialist and medical microbiologist. Dr. Quach is a clinician-scientist, supported by the Fonds de Recherche Québec – Santé (FRQS, chercheure boursière de mérite) and was recently awarded the Canada Research Chair, Tier 1 in Infection Prevention and Control. Her research interests are in Infection Prevention: both healthcare-associated and vaccine-preventable diseases. Dr. Quach is the former Chair of the National Advisory Committee on Immunization (NACI )from the Public Health Agency of Canada. She is a former president from the Association for Medical Microbiology and Infectious Diseases (AMMI) Canada (2014-2016). She was named Fellow of the Canadian Academy of Health Sciences and of the Society for Healthcare Epidemiology of America. Dr. Quach was selected as one of the 2019 most Powerful Women in Canada (2019 Top 100 Award Winner in the Manulife Science and Technology category).

🎙️FindMyVaccine is back with infectious diseases physician, Dr. Zain Chagla, who joins us from Toronto in studio. As we head into Fall 2024, it's not just the leaves changing-we cover the latest updates on COVID-19, new variants, new boosters, and new messaging we head into respiratory season. 🦠 In this episode, we cut through the noise and dive into what you need to know. ❓ Why is this surge happening again? We'll look at the data from this past summer's outbreaks and discuss why it's crucial to stay on top of this evolving situation. 🛡️ Booster blues? Vaccine uptake is still low among at-risk populations, and there's a new booster in town. But how do you communicate that effectively to patients without sounding like a broken record—or worse, adding to the confusion? 💡Navigating patient conversations around booster recommendations 🛑 and why the message has shifted. Get practical tips for identifying high-risk patients and translating NACI recommendations into action. It's not just about age; it's about timing, awareness, and making sure your patients understand why the next dose matters. 📅 Plus, we discuss how to prioritize COVID vs. flu vaccines.  🎧 Tune in for the latest on COVID, and more, with expert insights and a touch of humor. Key Concepts:COVID Surge Alert: Hospitalizations and test positivity are up again 🦠📈Vaccine Timing: Why it’s crucial to get your COVID shot now, with flu and RSV lurking around the corner. 🎯💉Cross-Neutralization Explained: How the new COVID variants differ and why updated vaccines still provide protection. 🧬🛡️COVID Therapeutics: Paxlovid effectiveness in the context of new variants🏃‍♂️📅Patient Conversations: Strategies for helping patients understand their risks and prioritize getting vaccinated. 🗣️👩‍⚕️    Dr. Zain ChaglaDr.Zain  Chagla, MD MSc MD, FRCPC  is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.  Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.  As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He  has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a  prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.

▶️🎧🎙️PART 2! Tools to use on the frontline and tips to engage your patients in 60 seconds or less. We untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead with 𝐃𝐫.Alan Kaplan and Dr.Marla Shapiro who break down all  you need to know. ✔️✔️We take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now? ✔️✔️We delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence? ✔️✔️We examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.  ✔️✔️We're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection? ✔️✔️Keeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.  Let’s dive in!  Dr.Alan Kaplan  Dr.Alan Kaplan, MD,  CCFP(EM), CPC(HC) is a  family Physician practicing in York Region, Ontario, Canada. Regional Primary Care Lead, Central Regional Cancer Program Chairperson of the Family Physician Airways Group of Canada Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada (www.fpagc.com) and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore. Alan’s other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.   Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP Professor, DFCM, University of Toronto Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society. Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer. Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS. Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this country’s highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation.   Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant

▶️🎧🎙️Today we untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead with 𝐃𝐫.Alan Kaplan and Dr.Marla Shapiro who break down all  you need to know. ✔️✔️We take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now? ✔️✔️We delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence? ✔️✔️We examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.  ✔️✔️We're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection? ✔️✔️Keeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.  Let’s dive in!  Dr.Alan Kaplan  Dr.Alan Kaplan, MD,  CCFP(EM), CPC(HC) is a  family Physician practicing in York Region, Ontario, Canada. Regional Primary Care Lead, Central Regional Cancer Program Chairperson of the Family Physician Airways Group of Canada Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada (www.fpagc.com) and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore. Alan’s other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.   Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP Professor, DFCM, University of Toronto Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society. Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer. Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS. Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this country’s highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation.

🎙️🎙️🎙️ ️ 𝐁𝐢𝐠 𝐍𝐞𝐰𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐡𝐞𝐚𝐫𝐭 𝐨𝐟 𝐂𝐚𝐧𝐚𝐝𝐚'𝐬 𝐜𝐚𝐩𝐢𝐭𝐚𝐥! 🍁 𝐖𝐞'𝐫𝐞 𝐭𝐡𝐫𝐢𝐥𝐥𝐞𝐝 𝐭𝐨 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐚𝐭 𝐰𝐞'𝐫𝐞 𝐥𝐚𝐮𝐧𝐜𝐡𝐢𝐧𝐠 𝐚 𝐩𝐨𝐝𝐜𝐚𝐬𝐭 𝐬𝐞𝐫𝐢𝐞𝐬 𝐬𝐭𝐫𝐚𝐢𝐠𝐡𝐭 𝐟𝐫𝐨𝐦 𝐎𝐭𝐭𝐚𝐰𝐚, 𝐛𝐫𝐨𝐚𝐝𝐜𝐚𝐬𝐭𝐢𝐧𝐠 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐚𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐂𝐈𝐂 𝟐𝟎𝟐𝟑. 𝐓𝐡𝐢𝐬 𝐞𝐩𝐢𝐬𝐨𝐝𝐞 𝐢𝐬 𝐲𝐨𝐮𝐫 𝐚𝐥𝐥-𝐚𝐜𝐜𝐞𝐬𝐬 𝐩𝐚𝐬𝐬 𝐭𝐨 𝐚 𝐜𝐮𝐫𝐚𝐭𝐞𝐝 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐨𝐧 𝐨𝐟 𝟑 𝐬𝐡𝐨𝐫𝐭 𝐜𝐨𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐨𝐧𝐬 𝐰𝐢𝐭𝐡 𝐜𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧 𝐭𝐡𝐨𝐮𝐠𝐡𝐭 𝐥𝐞𝐚𝐝𝐞𝐫𝐬  𝐚𝐧𝐝 𝐠𝐚𝐦𝐞 𝐜𝐡𝐚𝐧𝐠𝐞𝐫𝐬 𝐰𝐡𝐨 𝐚𝐫𝐞 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐩𝐮𝐛𝐥𝐢𝐜 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐛𝐞𝐲𝐨𝐧𝐝. 𝙏𝙪𝙣𝙚 𝙞𝙣, 𝙩𝙪𝙧𝙣 𝙪𝙥 𝙩𝙝𝙚 𝙫𝙤𝙡𝙪𝙢𝙚, 𝙖𝙣𝙙 𝙩𝙧𝙖𝙣𝙨𝙛𝙤𝙧𝙢 𝙩𝙤𝙜𝙚𝙩𝙝𝙚𝙧. 🎧 #𝘾𝙄𝘾2023 #𝙋𝙤𝙙𝙘𝙖𝙨𝙩 #𝙊𝙩𝙩𝙖𝙬𝙖     🎙️🎙️🎙️ MINI EPISODE 1: A Conversation with Dr.Sonia Anand MD, PhD, FRCPC 💡 💡 💡Ensuring immunization of structurally disadvantaged populations: Black People and other people of colour   Podcast Learning objectives • Describe how race-disaggregated data can allow for more targeted, community-specific interventions.  • Apply novel community-specific work to engage communities to support immunization.  • Illustrate how anti-Black racism presents a pervasive barrier to engaging with preventive health care initiatives.  For this mini podcast, we delve into how historical and systemic racism creates hurdles not only in understanding vaccine coverage discrepancies in Canada, but also in crafting effective, nuanced responses. We spotlight the distinctive obstacles Black and Asian communities in Canada have faced in accessing vaccines, both amidst the pandemic and prior to it. In the absence of detailed race-specific data for monitoring diseases preventable by vaccines and tracking vaccination rates, it is difficult to adequately cater to marginalized communities who face systemic barriers to healthcare access, including vaccinations. Dr.Anand unpacks this complex issue.   About Dr.Sonia Anand MD, PhD, FRCPC Professor of Medicine and Epidemiology, McMasterSenior Scientist Population Health Research InstituteTier 1 Canada Research Chair in Ethnic Diversity and Cardiovascular DiseaseHeart and Stroke Chair in Population HealthAssociate Chair of Equity and Diversity, Department of MedicineDirector of Chanchlani Research Centre  Dr. Sonia Anand is a professor in the Department of Medicine, and the Director of the Population Genomics Program, at McMaster. She is also a senior scientist at the Population Health Research Institute at Hamilton Health Sciences. Dr. Anand holds a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. In 2010, Dr. Anand was named among the top 100 women by the Women’s Executive Network for her accomplishments in research and medicine. Her current research focuses on environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease.   🎙️🎙️🎙️ MINI EPISODE 2: A Conversation with  Dr.Wayne Ghesquiere MD, FRCPC   💡 💡 💡Long-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: Interim efficacy, immunogenicity and safety results at approximately 10 years after initial vaccination     Podcast Learning objectives   • Discuss the interim efficacy of the adjuvanted recombinant zoster vaccine approximately 10 years post-vaccination.• Explain the immunogenicity of the adjuvanted recombinant zoster vaccine and how it contributes to its long-term protection against herpes zoster.• Evaluate the safety profile of the adjuvanted recombinant zoster vaccine based on data collected over approximately 10 years.• Analyze the significance of these interim results in the context of long-term vaccine strategies against herpes zoster.• Incorporate the provided insights into clinical practice and future research regarding herpes zoster vaccination strategies.• Communicate effectively to patients about the long-term benefits and safety of the adjuvanted recombinant zoster vaccineAbout Dr.Wayne Ghesquire MD, FRCPC Dr Wayne Ghesquiere is a Clinical Infectious Diseases, Tropical Diseases and Internal Medicine consultant in Victoria BC as well as the former section chief for infectious diseases with the Vancouver Island Health Authority, VIHA.   Wayne is a Clinical Assistant Professor of Medicine with University of British Columbia. Teaches internal medicine residents and infectious diseases fellows. He is an attending physician at the Royal Jubilee and the Victoria General Hospitals in Victoria, BC. He has an inpatient and a private outpatient practice in infectious diseases. Wayne is the chair and organizer of the annual Infectious Diseases Update in Victoria now in it’s 26th year. He is also the medical director of the Nova Travel Medicine and Immunization Clinic in Victoria. Current areas of interests include clinical research in Hepatitis B and C antiviral therapies, new vaccines, and teaching. He is a principal investigator of many clinical trials. He has publications in peer-reviewed medical journals including the NEJM, Lancet, Clinical Infectious Diseases, CMAJ, Open Medicine and others.     🎙️🎙️🎙️ MINI EPISODE 3: A Conversation  with Dr. Juthaporn Cowan, MD, FRCPC 💡 💡 💡Management of COVID-19 in immunocompromised patients: Are you up to date?   This podcast episode is centered around COVID-19 protection strategies for immunocompromised patients. Additionally, listeners will gain up to date insight into the range of tools available for these patients' protection and treatment, including antivirals and both active and passive vaccination methods. We'll also tackle ongoing concerns regarding the management of COVID-19 amidst the persistent emergence of new variants, emphasizing the necessity of regular revisits and modifications to these management strategies.   Podcast Learning Objectives   Describe the medical challenges faced by immunocompromised patients and discuss the unmet need for additional protection against SARS – CoV-2. Address the most recent data for prevention and treatment of COVID-19 in immunocompromised patients including the use of monoclonal antibodies.  Share best practices for the optimum clinical management of COVID-19 in immunocompromised patients in the current Canadian context.  About Dr. Juthaporn Cowan, MD, FRCPC Assistant Professor, Associate Scientist, The Ottawa Hospital Research Institute   Dr.Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Assistant Professor at The University of Ottawa, cross-appointed Assistant Professor at the Department of Biochemistry, Microbiology and Immunology and a Physician for the Division of Infectious Diseases at The Ottawa Hospital. Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa. Drs.D.William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic in Ottawa

🍁𝗙𝗼𝗿 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻𝘀, 𝗻𝗼𝘄 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗲𝘃𝗲𝗿, 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗼 𝘁𝗶𝗺𝗲𝗹𝘆, 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝘀 𝘁𝗼𝗽 𝗼𝗳 𝗺𝗶𝗻𝗱. 🍁𝗧𝗵𝗲 𝗖𝗮𝗻𝗮𝗱𝗮 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝗰𝘁, 𝘄𝗵𝗶𝗰𝗵 𝗼𝘂𝘁𝗹𝗶𝗻𝗲𝘀 𝘁𝗵𝗲 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗽𝗿𝗶𝗻𝗰𝗶𝗽𝗹𝗲𝘀 𝘁𝗵𝗮𝘁 𝗴𝗼𝘃𝗲𝗿𝗻 𝘁𝗵𝗲 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘆𝘀𝘁𝗲𝗺, 𝘄𝗮𝘀 𝗲𝘀𝘁𝗮𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗶𝗻 𝟭𝟵𝟴𝟰. ▶️𝗔 𝗹𝗼𝘁 𝗵𝗮𝘀 𝗰𝗵𝗮𝗻𝗴𝗲𝗱 𝘀𝗶𝗻𝗰𝗲 𝘁𝗵𝗲𝗻.   💡💡 💡💡 𝘿𝙤 𝙬𝙚 𝙣𝙚𝙚𝙙 𝙩𝙤 𝙨𝙩𝙚𝙥 𝙗𝙖𝙘𝙠 𝙖𝙣𝙙 𝙝𝙖𝙫𝙚 𝙩𝙝𝙚 𝙘𝙤𝙪𝙧𝙖𝙜𝙚 𝙩𝙤 𝙧𝙚𝙩𝙝𝙞𝙣𝙠 𝙘𝙖𝙧𝙚 𝙙𝙚𝙡𝙞𝙫𝙚𝙧𝙮 𝙞𝙣 𝙩𝙝𝙞𝙨 𝙘𝙤𝙪𝙣𝙩𝙧𝙮 𝙩𝙤 𝙧𝙚𝙛𝙡𝙚𝙘𝙩 𝙩𝙝𝙚 𝙘𝙝𝙖𝙣𝙜𝙞𝙣𝙜 𝙝𝙚𝙖𝙡𝙩𝙝 𝙣𝙚𝙚𝙙𝙨 𝙤𝙛 𝘾𝙖𝙣𝙖𝙙𝙞𝙖𝙣𝙨? 𝙄𝙨 𝙢𝙤𝙧𝙚 𝙢𝙤𝙣𝙚𝙮 𝙜𝙤𝙞𝙣𝙜 𝙩𝙤 𝙨𝙤𝙡𝙫𝙚 𝙩𝙝𝙚 𝙥𝙧𝙤𝙗𝙡𝙚𝙢? 𝗧𝗵𝗲 𝗿𝗶𝘀𝗸𝗶𝗲𝘀𝘁 𝗰𝗵𝗼𝗶𝗰𝗲 𝘀𝗼𝗺𝗲𝘁𝗶𝗺𝗲𝘀 𝗶𝘀 𝘁𝗼 𝘀𝘁i𝗰𝗸 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝘀𝘁𝗮𝘁𝘂𝘀 𝗾𝘂𝗼, 𝗲𝘀𝗽𝗲𝗰𝗶𝗮𝗹𝗹𝘆  𝘄𝗵𝗲𝗻 𝘄𝗲 𝘀𝗽𝗲𝗮𝗸 𝗼𝗳 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲.   🍁🎬 The premiers and the prime minister reached a new 10 year healthcare funding deal totaling $196 billion, with $46 billion in new funding with a tailored approach to the unique healthcare needs of each province and territory via bilateral deals. Provinces and territories in return must commit to health-care reform and improve transparency around data collection. 🍁▶️ We sit down with Canadian Prime Minister, Justin Trudeau, to chat about his vision for healthcare, opportunities and challenges, and what building accountability and innovation into these new bilateral healthcare agreements with each province and territory will, and can look like.   🍁🎙️ 🗨️  Whether you practice in BC or Newfoundland, 𝙬𝙝𝙚𝙩𝙝𝙚𝙧 𝙮𝙤𝙪'𝙧𝙚 𝙖 pharmacist, physician, nurse, nurse practitioner, or allied health professional, tune in to hear the PM’s personal message for our listeners and how the next generation of leaders in healthcare can play a meaningful role in shaping future of our healthcare system.   The Right Honourable Justin Trudeau, Prime Minister of Canada Justin Trudeau  is Canada’s 23rd Prime Minister. Justin’s vision of Canada is a country where everyone has a real and fair chance to succeed. His experiences as a teacher, father, leader, and advocate for youth have shaped his dedication to Canadians – and his commitment to make Canada a place where everyone has the opportunities they need to thrive. The oldest of three boys, Justin grew up with the profound influence of his father, Pierre Elliott Trudeau, and his mother, Margaret Trudeau. He was raised speaking both French and English and has family roots in both Eastern and Western Canada. This background helped spark his passion for public service and shaped his conviction that diversity is Canada’s strength. Justin studied literature at McGill University, graduating with a Bachelor of Arts (B.A.) in 1994. He went on to complete the University of British Columbia’s education program, and spent several years teaching French, math, and other subjects in Vancouver. Teaching allowed him to make a positive impact in the lives of young people. He remains committed to hearing the voices of young Canadians, from the classroom to Parliament Hill. Before entering politics, Justin served as the Chair of Katimavik, on the board for the Canadian Avalanche Foundation, and as an advocate for young people and the environment. As a speaker at events and conferences around the country, he encouraged young people to engage with the issues important to them and participate as active citizens. These experiences made it increasingly clear to him that the issues young Canadians care about – education, the environment, and their generation's economic prospects – needed a stronger voice. Justin entered politics to make change that would better serve all Canadians. In 2007, he built a community-based, grassroots campaign to win the Liberal Party nomination in the Montréal riding of Papineau. He was elected in 2008, and re-elected in 2011, 2015, and 2019. Justin was elected Leader of the Liberal Party in April 2013. His leadership campaign focused on building a new, truly national movement of progressive Canadians, bringing hundreds of thousands of Canadians into politics, most for the first time. He worked closely with his team to build a plan to create jobs, grow the economy, protect the environment, and strengthen the middle class. With Justin’s leadership, the Liberal plan emphasized fair economic opportunity for everyone, respect for and promotion of freedom and diversity, and a more democratic government that truly represents Canadians. On October 19, 2015, Justin led his party to victory, winning a majority government with seats in every province and territory across the country. He was sworn in on November 4, 2015. On October 21, 2019, Justin led the Liberal Party to re-election, earning a second mandate from Canadians. As Prime Minister, Justin leads a government that works hard every day to continue moving Canada forward. His team is focused on creating good middle class jobs, making life more affordable, keeping Canada’s communities safe, fighting climate change, and moving forward on reconciliation with Indigenous peoples. A proud feminist, Justin appointed Canada’s first gender balanced Cabinet. VODCAST OF THIS EPISODE AVAILABLE HERE: https://www.myvaccinepodcast.com/vodcast#Trudeau

🎬NOTE: Episode recorded in early Fall (September) as leadership candidate prior to David officially becoming Premier. ****** ☎️  Today, David Eby was sworn in as British Columbia’s 37th premier. 🗨️ We sit down with Premier Eby to discuss his plans for the Province's #𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘀𝘆𝘀𝘁𝗲𝗺, 𝗶𝗻𝗰𝗹𝘂𝗱𝗶𝗻𝗴 everything from 𝗲𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 #patient 𝗮𝗰𝗰𝗲𝘀𝘀 by expanding 𝘁𝗵𝗲 𝘀𝘂𝗶𝘁𝗲 𝗼𝗳 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 #𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗶𝘀𝘁𝘀 𝗮𝗻𝗱 𝗼𝘁𝗵𝗲𝗿 #𝗛𝗖𝗣𝘀 𝗰𝗼𝘂𝗹𝗱 𝗽𝗿𝗼𝘃𝗶𝗱𝗲, reforming primary care, and if outdated legislation around patient rights is meeting the needs of today's patients.   🎬 🎙️ 𝗜𝘁'𝘀 𝗻𝗼𝘁 𝗱𝗶𝗳𝗳𝗶𝗰𝘂𝗹𝘁 𝘁𝗼 𝗮𝗿𝗴𝘂𝗲 𝘁𝗵𝗮𝘁 𝗮 𝘁𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗺𝗶𝗻𝗱𝘀𝗲𝘁 𝗰𝗮𝗻 𝗯𝗲 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗴𝗶𝗻𝗴 𝘁𝗼 𝘁𝗮𝗰𝗸𝗹𝗲 𝘄𝗵𝗲𝗻 𝘄𝗲 𝘁𝗵𝗶𝗻𝗸 𝗮𝗯𝗼𝘂𝘁 #𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗮𝗻𝗱 𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗰𝗲𝗻𝘁𝗲𝗿𝗲𝗱 𝗰𝗮𝗿𝗲 𝗶𝗻 𝗖𝗮𝗻𝗮𝗱𝗮. 𝗜𝗻 𝗮 𝘁𝗶𝗺𝗲 𝗼𝗳 𝗰𝗿𝗶𝘀𝗶𝘀, 𝗱𝗼 𝘄𝗲 𝗻𝗲𝗲𝗱 𝗮 𝗳𝘂𝗻𝗱𝗮𝗺𝗲𝗻𝘁𝗮𝗹 𝘀𝗵𝗶𝗳𝘁 𝗮𝗯𝗼𝘂𝘁 𝗵𝗼𝘄 𝘄𝗲 𝘁𝗵𝗶𝗻𝗸 𝗮𝗯𝗼𝘂𝘁 #𝗽𝗿𝗶𝗺𝗮𝗿𝘆 𝗰𝗮𝗿𝗲 𝗮𝗻𝗱 #𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝘁𝘁𝗮𝗰𝗵𝗺𝗲𝗻𝘁?   Questions we ask:     💡💡 𝑫𝒐𝒆𝒔 𝒆𝒗𝒆𝒓𝒚 𝑪𝒂𝒏𝒂𝒅𝒊𝒂𝒏 𝒏𝒆𝒆𝒅 𝒂𝒄𝒄𝒆𝒔𝒔 𝒕𝒐 𝒂 𝑮𝑷, 𝒐𝒓 𝒅𝒐𝒆𝒔 𝒆𝒗𝒆𝒓𝒚 𝑪𝒂𝒏𝒂𝒅𝒊𝒂𝒏 𝒏𝒆𝒆𝒅 𝒂𝒄𝒄𝒆𝒔𝒔 𝒕𝒐 𝒉𝒊𝒈𝒉-𝒒𝒖𝒂𝒍𝒊𝒕𝒚 #𝒑𝒓𝒊𝒎𝒂𝒓𝒚 𝒄𝒂𝒓𝒆 𝒔𝒆𝒓𝒗𝒊𝒄𝒆𝒔-𝒘𝒉𝒂𝒕𝒆𝒗𝒆𝒓 𝒕𝒉𝒆 𝒎𝒂𝒌𝒆𝒖𝒑 𝒂𝒏𝒅 𝒎𝒊𝒙 𝒐𝒇 𝒕𝒉𝒐𝒔𝒆 #𝒑𝒓𝒊𝒎𝒂𝒓𝒚 𝒄𝒂𝒓𝒆 service 𝒍𝒐𝒐𝒌 𝒍𝒊𝒌𝒆? 🎬𝑫𝒐𝒆𝒔 𝒓𝒆𝒇𝒐𝒓𝒎𝒊𝒏𝒈 𝒑𝒓𝒊𝒎𝒂𝒓𝒚 𝒄𝒂𝒓𝒆 𝒔𝒕𝒂𝒓𝒕 𝒘𝒊𝒕𝒉 𝒓𝒆𝒇𝒓𝒂𝒎𝒊𝒏𝒈 𝒑𝒓𝒊𝒎𝒂𝒓𝒚 𝒄𝒂𝒓𝒆?     ▶️ 𝑰𝒇 𝑰 𝒔𝒆𝒆 50 𝒑𝒂𝒕𝒊𝒆𝒏𝒕𝒔 𝒂𝒏𝒅 𝒚𝒐𝒖 𝒔𝒆𝒆 20 𝒑𝒂𝒕𝒊𝒆𝒏𝒕𝒔 𝒂 𝒅𝒂𝒚, 𝒘𝒉𝒐 𝒊𝒔 𝒅𝒆𝒍𝒊𝒗𝒆𝒓𝒊𝒏𝒈 𝒃𝒆𝒕𝒕𝒆𝒓 #𝒄𝒂𝒓𝒆? 𝑰𝒔 𝒕𝒉𝒂𝒕 𝒆𝒗𝒆𝒏 𝒕𝒉𝒆 𝒓𝒊𝒈𝒉𝒕 𝒒𝒖𝒆𝒔𝒕𝒊𝒐𝒏 𝒕𝒐 𝒂𝒔𝒌?  💡💡 𝗟𝗶𝗻𝗸𝗶𝗻𝗴 #𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 #𝗽𝗿𝗼𝘃𝗶𝗱𝗲𝗿 𝗿𝗲𝗺𝘂𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝘄𝗶𝘁𝗵 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗼𝗳 #𝗰𝗮𝗿𝗲, 𝘀𝗲𝗿𝘃𝗶𝗰𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗺𝗲𝘁𝗿𝗶𝗰𝘀, 𝗮𝗻𝗱 #𝗼𝘂𝘁𝗰𝗼𝗺𝗲𝘀 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗮 𝗰𝗼𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗮𝘁'𝘀 𝗯𝗲𝗲𝗻 𝗵𝗮𝗱 𝗳𝗼𝗿 𝘆𝗲𝗮𝗿𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝗖𝗮𝗻𝗮𝗱𝗮.🇨🇦   🎙️𝗪𝗵𝗮𝘁 𝘄𝗶𝗹𝗹 𝗶𝘁 𝘁𝗮𝗸𝗲 𝘁𝗼 𝗺𝗮𝗸𝗲 𝘁𝗵𝗲 𝘀𝗵𝗶𝗳𝘁 broadly across our healthcare 𝗳𝗿𝗼𝗺 #𝘃𝗼𝗹𝘂𝗺𝗲 𝘁𝗼 #𝘃𝗮𝗹𝘂𝗲 𝗯𝗮𝘀𝗲𝗱 𝗰𝗮𝗿𝗲 and why are we not there yet?   ABOUT DAVID EBY, KC  David Eby, K.C.David Eby is the MLA for Vancouver-Point Grey, first elected in 2013. Before he was elected, David was the Executive Director of the BC Civil Liberties Association, an adjunct professor of law at the University of British Columbia, president of the HIV/AIDS Legal Network, and served on the Vancouver Foundation's Health and Social Development Committee. An award-winning human rights lawyer, he has been repeatedly recognized in local media as one of British Columbia's most effective advocates and has appeared at all levels of court in BC. His years of legal advocacy at Pivot Legal Society to protect the human rights and dignity of homeless and under-housed residents of Vancouver's Downtown Eastside were recognized in 2011 by the UN Association in Canada and the B.C. Human Rights Coalition with their annual award.

▶️  🗨️ We are excited to sit down with Canada's Chief Public Health Officer, Dr.Theresa Tam, to discuss her personal thoughts about how this pandemic has  reshaped how we think about public health's role and new opportunities to synergize with frontline healthcare providers.   🎬🎙️ Often climate change is not a top of mind issue  when it comes to healthcare planning and resource allocation. In anticipation of Dr.Tam's upcoming Annual report, we deep dive into how public health is building in plans to address climate change, extreme weather event, and the changing endemicity of transmissible diseases as a result. 💡   You also don't want to miss Dr.Tam's secret talent. 🎬NOTE: Links added below to Dr.Theresa Tam's Annual Report: Mobilizing Public Health Action on Climate Change in Canada as episode was recorded prior to release****** https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/state-public-health-canada-2022/report.html -------- 🟢 EPISODE TIME STAMPS🟢 02:08  Intro   04:21  Dr.Tam's journey from practitioner to public health leader     07:48   Dealing with being a very public face and the pressures that come with it   14:55 Planning for the future of public health in Canada and the next "x" factor   21:18 Addressing gaps and needs in healthcare communication     28:36 Mapping synergy betwen frontline healthcare providers and public health in Canada   31:03 At the intersection of climate change and public health planning   35:09 What does Dr. Tam  have to say to the next generation of leaders on the front line and potentially leaders in public              health? -------- 🎙️ ABOUT DR.THERESA TAM Dr. Theresa Tam was named Canada's Chief Public Health Officer on June 26, 2017. She is a paediatric infectious disease specialist with expertise in immunization, emergency preparedness and global health security. Dr. Tam obtained her medical degree from the University of Nottingham in the U.K. She completed her paediatric residency at the University of Alberta and her fellowship in paediatric infectious diseases at the University of British Columbia. She is a Fellow of the Royal College of Physicians and Surgeons of Canada and has over 55 peer-reviewed journal publications in public health. She is also a graduate of the Canadian Field Epidemiology Program. Dr. Tam has held several senior leadership positions at the Public Health Agency of Canada, including as the Deputy Chief Public Health Officer and the Assistant Deputy Minister for Infectious Disease Prevention and Control. During her 25 years in public health, she provided technical expertise and leadership on new initiatives to improve communicable disease surveillance, enhance immunization programs, strengthen health emergency management and laboratory biosafety and biosecurity. She has played a leadership role in Canada's response to public health emergencies including severe acute respiratory syndrome (SARS), pandemic influenza H1N1 and Ebola. Dr. Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.

Your COVID vaccine is getting a makeover (well kind of). Freshly formulated updated Omicron-specific COVID-19 vaccines are now available. These  new bivalent booster shots rolling out across Canada are specifically tailored to match currently circulating COVID omicron variants and are thought to provide enhanced protection against newer versions of SARS-CoV-2 than our earlier shots. Uptake of booster vaccines has not been anywhere near as high as the initial vaccines. ▶️🎧 🎙️ 𝐖𝐞 𝐬𝐢𝐭 𝐝𝐨𝐰𝐧 𝐰𝐢𝐭𝐡 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐞𝐱𝐩𝐞𝐫t, 𝐃𝐫.𝐙𝐚𝐢𝐧 𝐂𝐡𝐚𝐠𝐥𝐚 who breaks down all  you need to know about (in less than 36 minutes):  ✔️✔️How do you approach and recommend the updated bivalent COVID-19 booster to eligible patients ✔️✔️How should you be framing the efficacy conversation in relation to this bivalent booster-antibody data vs clinical effectiveness ✔️✔️Strategies to increase booster uptake in clinical practice ✔️✔️Key practicalities of the vaccine and how this would fit into your daily practice?   ✔️✔️Are breakthrough infections less likely with this updated bivalent booster?   ✔️✔️Will this booster still work if the virus mutates again and there’s a new variant? ✔️✔️ What does the healthcare provider  need to know from this discussion to communicate with a patient the next day?     Dr. Zain ChaglaDr.Zain  Chagla, MD MSc MD, FRCPC  is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.  Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.  As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He  has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a  prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.